Friday, 19 April 2024


Malaysian Genomics collaborates with NIH to explore research opportunities

12 October 2022 | News

To collaborate on research in genomics and biopharmaceuticals

Photo Credit: ACN Newswire

Photo Credit: ACN Newswire

MGRC Therapeutics Sdn Bhd (MGRC-T), a wholly-owned subsidiary of Malaysian Genomics Resource Centre Berhad, has entered into a cooperation agreement with the National Institutes of Health, Malaysia (NIH), providing a framework for collaboration between the two parties in medical research pertaining to genomics and biopharmaceuticals.

The National Institutes of Health (NIH), the research arm under the Ministry of Health Malaysia, comprises six research institutes that focus on biomedical research, public health and epidemiology, clinical research, behavioural health research, health management and health policies. The health research conducted by the NIH is in line with the Health Research Priority Areas for each five-yearly Malaysia Plans to improve Malaysians life quality .

MGRC-T specialises in genomics and biopharmaceutical services with proprietary know-how and intellectual property related to the research, development, and processing of genetic screening tests, as well as the manufacturing of cell therapies, including immunotherapy for various types of cancer.
 
Under this agreement, the parties will explore joint training in the field of medical research, exchange research materials, and partake in scientific data presentation and publication. As part of the agreement, experts and personnel will be exchanged, including postgraduate research and adjunct students, short and long-term research attachments, co-supervising research and internships by students, and other areas of mutual cooperation.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account